IRONWOOD PHARMACEUTICALS, INC.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $215.5M | $88.6M | $92.2M | $656.2M | $620.1M | $362.6M | $177.0M | $173.2M |
| Accounts Receivable | $46.7M | $81.9M | $129.1M | $115.5M | $114.0M | $122.4M | $11.3M | $21.0M |
| Inventory | — | — | — | — | — | — | $648.0K | — |
| Total Current Assets | $274.2M | $182.4M | $233.3M | $780.6M | $745.2M | $495.8M | $306.9M | $266.4M |
| Property, Plant & Equipment | $3.4M | $4.5M | $5.6M | $6.3M | $7.6M | $8.9M | $12.4M | $7.7M |
| Goodwill | — | — | — | — | — | — | $785.0K | $785.0K |
| Intangible Assets (Excl. Goodwill) | $2.0M | $2.9M | $3.7M | — | — | — | — | — |
| Total Assets | $396.9M | $350.9M | $471.1M | $1.10B | $1.13B | $559.2M | $402.7M | $332.1M |
| Liabilities | ||||||||
| Accounts Payable | $2.9M | $2.1M | $7.8M | $483.0K | $935.0K | $661.0K | $4.0M | $14.9M |
| Total Current Liabilities | $242.2M | $38.8M | $276.1M | $25.5M | $161.7M | $32.2M | $40.9M | $119.5M |
| Long-Term Debt | — | — | — | $396.3M | $454.2M | $430.3M | — | — |
| Total Liabilities | $658.7M | $652.2M | $817.4M | $448.1M | $521.0M | $496.6M | $496.0M | $528.4M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.67B | $-1.70B | $-1.70B | $-696.4M | $-937.6M | $-1.47B | $-1.57B | $-1.59B |
| Total Stockholders' Equity | $-261.8M | $-301.3M | $-346.3M | $652.4M | $605.9M | $62.6M | $-93.3M | $-196.4M |